The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Argininemia Drugs Market Research Report 2025

Global Argininemia Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1536760

No of Pages : 75

Synopsis
Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.
The global Argininemia Drugs market was valued at US$ 102.5 million in 2023 and is anticipated to reach US$ 137 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The Arginase deficiency drugs market is driven by the growing awareness and diagnosis of this rare genetic disorder. As understanding of the disease improves, more patients are being identified and seeking treatment options. The development of targeted therapies to address the underlying metabolic abnormalities associated with Arginase deficiency has also contributed to market growth. Additionally, government initiatives and orphan drug designations have facilitated research and development in this area. However, the market faces challenges like limited patient populations, high treatment costs, and the need for specialized medical expertise for diagnosis and management. Overcoming these challenges through increased awareness, early diagnosis, and affordable access to therapies will be essential for the sustained growth of the Arginase deficiency drugs market.
This report aims to provide a comprehensive presentation of the global market for Argininemia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Argininemia Drugs.
Report Scope
The Argininemia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Argininemia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Argininemia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Helsinn Healthcare
Novartis Pharmaceuticals
Horizo​​n Pharma
Medicis Pharmaceutical
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drugs Stores
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Argininemia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Argininemia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Argininemia Drugs Market Overview
1.1 Product Overview and Scope of Argininemia Drugs
1.2 Argininemia Drugs Segment by Type
1.2.1 Global Argininemia Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.3 Argininemia Drugs Segment by Application
1.3.1 Global Argininemia Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Global Argininemia Drugs Market Size Estimates and Forecasts
1.4.1 Global Argininemia Drugs Revenue 2019-2030
1.4.2 Global Argininemia Drugs Sales 2019-2030
1.4.3 Global Argininemia Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Argininemia Drugs Market Competition by Manufacturers
2.1 Global Argininemia Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Argininemia Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Argininemia Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Argininemia Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Argininemia Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Argininemia Drugs, Product Type & Application
2.7 Argininemia Drugs Market Competitive Situation and Trends
2.7.1 Argininemia Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Argininemia Drugs Players Market Share by Revenue
2.7.3 Global Argininemia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Argininemia Drugs Retrospective Market Scenario by Region
3.1 Global Argininemia Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Argininemia Drugs Global Argininemia Drugs Sales by Region: 2019-2030
3.2.1 Global Argininemia Drugs Sales by Region: 2019-2024
3.2.2 Global Argininemia Drugs Sales by Region: 2025-2030
3.3 Global Argininemia Drugs Global Argininemia Drugs Revenue by Region: 2019-2030
3.3.1 Global Argininemia Drugs Revenue by Region: 2019-2024
3.3.2 Global Argininemia Drugs Revenue by Region: 2025-2030
3.4 North America Argininemia Drugs Market Facts & Figures by Country
3.4.1 North America Argininemia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Argininemia Drugs Sales by Country (2019-2030)
3.4.3 North America Argininemia Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Argininemia Drugs Market Facts & Figures by Country
3.5.1 Europe Argininemia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Argininemia Drugs Sales by Country (2019-2030)
3.5.3 Europe Argininemia Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Argininemia Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Argininemia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Argininemia Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Argininemia Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Argininemia Drugs Market Facts & Figures by Country
3.7.1 Latin America Argininemia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Argininemia Drugs Sales by Country (2019-2030)
3.7.3 Latin America Argininemia Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Argininemia Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Argininemia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Argininemia Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Argininemia Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Argininemia Drugs Sales by Type (2019-2030)
4.1.1 Global Argininemia Drugs Sales by Type (2019-2024)
4.1.2 Global Argininemia Drugs Sales by Type (2025-2030)
4.1.3 Global Argininemia Drugs Sales Market Share by Type (2019-2030)
4.2 Global Argininemia Drugs Revenue by Type (2019-2030)
4.2.1 Global Argininemia Drugs Revenue by Type (2019-2024)
4.2.2 Global Argininemia Drugs Revenue by Type (2025-2030)
4.2.3 Global Argininemia Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Argininemia Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Argininemia Drugs Sales by Application (2019-2030)
5.1.1 Global Argininemia Drugs Sales by Application (2019-2024)
5.1.2 Global Argininemia Drugs Sales by Application (2025-2030)
5.1.3 Global Argininemia Drugs Sales Market Share by Application (2019-2030)
5.2 Global Argininemia Drugs Revenue by Application (2019-2030)
5.2.1 Global Argininemia Drugs Revenue by Application (2019-2024)
5.2.2 Global Argininemia Drugs Revenue by Application (2025-2030)
5.2.3 Global Argininemia Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Argininemia Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Helsinn Healthcare
6.1.1 Helsinn Healthcare Corporation Information
6.1.2 Helsinn Healthcare Description and Business Overview
6.1.3 Helsinn Healthcare Argininemia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Helsinn Healthcare Argininemia Drugs Product Portfolio
6.1.5 Helsinn Healthcare Recent Developments/Updates
6.2 Novartis Pharmaceuticals
6.2.1 Novartis Pharmaceuticals Corporation Information
6.2.2 Novartis Pharmaceuticals Description and Business Overview
6.2.3 Novartis Pharmaceuticals Argininemia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Pharmaceuticals Argininemia Drugs Product Portfolio
6.2.5 Novartis Pharmaceuticals Recent Developments/Updates
6.3 Horizo​​n Pharma
6.3.1 Horizo​​n Pharma Corporation Information
6.3.2 Horizo​​n Pharma Description and Business Overview
6.3.3 Horizo​​n Pharma Argininemia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Horizo​​n Pharma Argininemia Drugs Product Portfolio
6.3.5 Horizo​​n Pharma Recent Developments/Updates
6.4 Medicis Pharmaceutical
6.4.1 Medicis Pharmaceutical Corporation Information
6.4.2 Medicis Pharmaceutical Description and Business Overview
6.4.3 Medicis Pharmaceutical Argininemia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medicis Pharmaceutical Argininemia Drugs Product Portfolio
6.4.5 Medicis Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Argininemia Drugs Industry Chain Analysis
7.2 Argininemia Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Argininemia Drugs Production Mode & Process
7.4 Argininemia Drugs Sales and Marketing
7.4.1 Argininemia Drugs Sales Channels
7.4.2 Argininemia Drugs Distributors
7.5 Argininemia Drugs Customers
8 Argininemia Drugs Market Dynamics
8.1 Argininemia Drugs Industry Trends
8.2 Argininemia Drugs Market Drivers
8.3 Argininemia Drugs Market Challenges
8.4 Argininemia Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’